Psoralen may be able to play a role as a potential inhibitor of JAK2 and PI3K in the treatment of glioma, but the data in this study is only limited to the effects of psoralen on two glioma cell lines in vitro, and further insights are required to explore the extensive experimental research in this domain. The gene discussed is PIK3CA; the disease is glioma.